Ignite Creation Date:
2024-05-05 @ 5:15 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00413283
Status:
COMPLETED
Last Update Posted:
2013-10-24
First Post:
2006-12-15
Brief Title:
Dose Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia CIT in Non-Small Cell Lung Cancer NSCLC
Sponsor:
Amgen
Organization:
Amgen
Organization Data
Organization:
Amgen
Class:
INDUSTRY
Study ID:
20050154
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amgen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None